C
ChromaCode
Pioneering advancements by integrating reliable biochemical techniques with computational mathematics to enhance performance in testing, at a very low cost
About ChromaCode
ChromaCode is a pioneering molecular diagnostics company that is revolutionizing precision diagnostics through advanced multiplexing technology. The company serves clinical laboratories and healthcare providers, operating within the molecular diagnostics market. ChromaCode's core product, HDPCR technology, significantly expands the number of detectable disease targets in a single reaction, up to four times more than traditional methods. This is achieved without requiring changes to existing qPCR or dPCR instruments, making it a cost-effective solution for labs. The business model revolves around selling enhanced PCR reagents and cloud-based software, generating revenue through the sale of these products and associated services. By leveraging digital signal processing, ChromaCode enables broader coverage and more rapid disease identification, ultimately reducing costs and increasing efficiency for its clients.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Carlsbad, United States
- Employees
- 19
- Open positions
- None listed
- Dealroom signal
- 77.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Tech for Biotech and Pharma, Biotech and Pharma, DT and LS, science-based
- Business model
- SaaS
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning ChromaCode.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jun 2023 | $0 | — | Global Brain Corporation · Shimadzu | ↗ |
| GRANTOther financing | Mar 2021 | $6M | — | X PRIZE Foundation | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for ChromaCode is 490 monthly website visits, down 24.6% over the last three months. ChromaCode's team grew 5.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
X PRIZE Foundation
Series A3 investors entered at this stage
NEA
Domain Associates
Okapi Venture Capital
Series B and later6 investors entered at this stage
Northpond Ventures
Moore Venture Partners
Windham Venture Partners
Adjuvant Capital
Global Brain Corporation
Shimadzu
Other known investors1 additional known investor
Caltech, California Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ChromaCode on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ChromaCode’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.